Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Paar

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1988
Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccineN Scheiermann, K M Gesemann, D Paar, et al.
Der Internist|December 29, 2000
[52-year-old patient with pleural effusion after a stay in Cameroon]N Morakkabati, W D Paar, H H Schild, et al.
Medizinische Klinik|February 13, 1970
[Serum protein changes in infection with Leptospira icterohaemorrhagiae]G Cohnen, O Schriever, I Fonk, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasmaW D Paar, H Schuhler, R Fimmers, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadolW D Paar, S Poche, J Gerloff, et al.
Isotopes in Environmental and Health Studies|December 17, 1998
Labelling studies for structure elucidation of a new hydroxymetabolite of tramadolU Potyka, W D Paar, T Sauerbruch, et al.
Isotopes in Environmental and Health Studies|November 18, 2011
Labelling studies for structure elucidation of a new hydroxymetabolite of tramadolU Potyka, W D Paar, T Sauerbruch, et al.
Lancet (London, England)|June 5, 1971
Abnormal alpha-1-lipoprotein with impaired binding capacity for lipidH J Roggenbach, W Augener, K Rosenstiel, et al.
Clinical Nephrology|February 13, 1999
Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patientsT S Ahuja, N Niaz, A Velasco, et al.
Der Anaesthesist|March 1, 1994
[The effect of substitution with AT III- and PPSB-concentrates in patients with terminal liver insufficiency]R Scherer, A Gille, J Erhard, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1988
Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccineN Scheiermann, K M Gesemann, D Paar, et al.
Der Internist|December 29, 2000
[52-year-old patient with pleural effusion after a stay in Cameroon]N Morakkabati, W D Paar, H H Schild, et al.
Medizinische Klinik|February 13, 1970
[Serum protein changes in infection with Leptospira icterohaemorrhagiae]G Cohnen, O Schriever, I Fonk, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasmaW D Paar, H Schuhler, R Fimmers, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadolW D Paar, S Poche, J Gerloff, et al.
Isotopes in Environmental and Health Studies|December 17, 1998
Labelling studies for structure elucidation of a new hydroxymetabolite of tramadolU Potyka, W D Paar, T Sauerbruch, et al.
Isotopes in Environmental and Health Studies|November 18, 2011
Labelling studies for structure elucidation of a new hydroxymetabolite of tramadolU Potyka, W D Paar, T Sauerbruch, et al.
Lancet (London, England)|June 5, 1971
Abnormal alpha-1-lipoprotein with impaired binding capacity for lipidH J Roggenbach, W Augener, K Rosenstiel, et al.
Clinical Nephrology|February 13, 1999
Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patientsT S Ahuja, N Niaz, A Velasco, et al.
Der Anaesthesist|March 1, 1994
[The effect of substitution with AT III- and PPSB-concentrates in patients with terminal liver insufficiency]R Scherer, A Gille, J Erhard, et al.
Pageof 11